Protecting the brain after cardiac arrest

May 24, 2017

By Jan Jarvis

Mallet_web

A new treatment identified by UNT Health Science researchers may protect the brain from irreversible brain damage caused by cardiac arrest.

The discovery, published in the May issue of Experimental Biology and Medicine, could offer hope to the more than 500,000 people in the United States who suffer a cardiac arrest each year. Currently there are few treatments available to help these patients.

The brain consumes enormous amounts of metabolic energy and is dependent on its blood supply to deliver energy-yielding fuels and oxygen. When the brain’s blood supply is interrupted, such as during a cardiac arrest, the brain rapidly depletes its energy reserves and toxic metabolites accumulate.

This leads to damage in the molecular components of the brain’s cells, including proteins. As a result, only 8 percent of those who suffer a cardiac arrest outside the hospital survive with brain function intact, said Robert Mallet, PhD, Professor, Institute for Cardiovascular and Metabolic Disease.

“Cardiac arrest is devastating because it severely injures the brain,” Dr. Mallet said. “Moreover, those who are fortunate enough to survive cardiac arrest may be at increased risk of developing senile dementia.”

Cardiac arrest triggers the production of the metabolite methylglyoxal, a byproduct of sugar metabolism that damages proteins and may cause permanent impairment of brain function. In the lab, a research team led by Dr. Mallet found that glyoxalase and other protective enzymes were inactivated following cardiac arrest and CPR, weakening the brain’s natural defenses against methylglyoxal and other toxins.

But giving patients an intravenous infusion of an energy fuel and antioxidant called pyruvate may restore these defenses and preserve functional brain proteins, according to the study. Pyruvate is a natural metabolite that protects the brain against methylglyoxal when given in a timely fashion, Dr. Mallet said.

“Pyruvate could be an ideal brain protectant because it is effective in humans, is chemically stable and has no adverse side effects,” Dr. Mallet said.

Dr Vishwanatha
UNTHSC splits $2.2 million cancer disparities grant

By Alex Branch   A new collaboration between UNT Health Science Center and Langston University seeks to reduce cancer health disparities and prepare minority scholars to perform ground-breaking medical research. UNTHSC and Langston, a historically black college in Oklahoma, recently ce...Read more

Oct 22, 2018

Md Fc
TCU and UNTHSC School of Medicine awarded preliminary accreditation

By Maricar Estrella   Fort Worth is now home to the nation’s newest M.D. School. The Liaison Committee on Medical Education awarded preliminary accreditation to the TCU and UNTHSC School of Medicine, opening the doors for student recruitment. The first class of 60 medical students is e...Read more

Oct 19, 2018

Ireb Fc
New IREB praised as both a work of art and a technological wonder

By Jan Jarvis   As she stood on the first floor of the new Interdisciplinary Research and Education Building, Alyssa Wilder envisioned herself spending a lot of time there. “Oh my gosh there’s so much space and look at all this glass,” said Wilder, a first-year Texas College of O...Read more

Oct 19, 2018

Frank Fc
TCOM earns 10-year accreditation with highest distinction

By Alex Branch   The Texas College of Osteopathic Medicine was granted a 10-year Accreditation with Exceptional Outcome, the highest level of accreditation given by the American Osteopathic Association’s Commission on Osteopathic College Accreditation (COCA). “We’re very plea...Read more

Oct 17, 2018